| Title |
Author |
Type |
Date |
Words |
| Cassava Fufu boosts immune system, lowers blood pressure Study. |
|
|
Jul 3, 2022 |
2334 |
| Study: Cassava fufu boosts immune system, lowers blood pressure. |
Josephine Nettey |
|
Jul 1, 2022 |
2376 |
| Clinical efficacy of intravesical gemcitabine combined with ubenimex in patients with non-muscle-invasive bladder carcinoma after transurethral resection of bladder tumor. |
Li-jun Shao, Hai-jiang Wang, Jia-rong Wang, Xiao-fei Yuan and Quan Sha |
|
Jun 30, 2022 |
3158 |
| 5 Ways to Boost Immunity While You're Traveling. |
|
|
Jun 30, 2022 |
766 |
| Ozonated Therapy reduces the risk of diabetes complications, improves immunity. |
|
|
Jun 30, 2022 |
1031 |
| Agenus announces expanded data from Phase 1b study of botensilimab, balstilimab. |
|
|
Jun 29, 2022 |
219 |
| Study: Cassava fufu Boosts immune System, lowers Blood Pressure. |
|
|
Jun 28, 2022 |
2339 |
| Take a 30 minute lunchtime power nap to boost your health, claims sleep expert; Daytime power naps between 1pm and 3pm are vital for optimum health, claims health expert Nick Little-Hales. Do you take a cheeky lunchtime nap? |
By, Freya Hodgson |
|
Jun 28, 2022 |
824 |
| Pan-Cancer Analysis Predicts the Immunological and Prognostic Role of ZC3H12C in KIRC. |
Yue, Yanping; Wu, Yumeng; Zhao, Dakun; Wu, Biao; Wu, Xuming; Liu, Jibin; Yang, Lei |
|
Jun 26, 2022 |
5530 |
| Construction of Metabolic Molecular Classification and Immune Characteristics for the Prognosis Prediction of Ovarian Cancer. |
Wang, Kexin; He, Hui; Feng, Xue |
|
Jun 25, 2022 |
8514 |
| Predictive Potentials of ZEB1-AS1 in Colorectal Cancer Prognosis and Their Correlation with Immunotherapy. |
Ruan, Liqin; Chen, Weili; Zhao, Xinhua; Fang, Ningbo; Li, Taiyuan |
|
Jun 25, 2022 |
4170 |
| BriaCell announces publication on Bria-IMT data. |
|
|
Jun 24, 2022 |
196 |
| After cracking COVID-19, BioNTech hunts vaccine for cancer. |
|
|
Jun 22, 2022 |
669 |
| Four-Pyroptosis Gene-Based Nomogram as a Novel Strategy for Predicting the Effect of Immunotherapy in Hepatocellular Carcinoma. |
Li, Ning; Ren, Shao-hua; Qin, Ya-fei; Shao, Bo; Qin, Hong; Wang, Zhaobo; Wang, Hong-da |
|
Jun 22, 2022 |
7051 |
| Targeting Inhibition of Accumulation and Function of Myeloid-Derived Suppressor Cells by Artemisinin via PI3K/AKT, mTOR, and MAPK Pathways Enhances Anti-PD-L1 Immunotherapy in Melanoma and Liver Tumors. |
Zhang, Mengqi; Wang, Lulu; Liu, Wan; Wang, Tian; De Sanctis, Francesco; Zhu, Lifang; Zhang, Guizhong |
|
Jun 22, 2022 |
10540 |
| Pan-Cancer Pyroptosis Analyses Identified Novel Immunology and Chemotherapy-Related Prognostic Signatures in Cancer Subtypes. |
Li, Canrong; Lin, Cha; Xie, Xiaoduo |
|
Jun 20, 2022 |
9549 |
| Cold Remedies: Best, worst drinks to boost immune, fight sickness. |
|
|
Jun 20, 2022 |
1008 |
| Semaphorin-3 Promotes Specific Immunotherapy Effects on Experimental Food Allergy. |
Huang, Huang; Liu, Yu; Wang, Yanan; Liu, Huazhen; Xie, Bailing; Zheng, Michael B. W.; Yang, Liteng |
|
Jun 19, 2022 |
6559 |
| Metformin Facilitates Osteoblastic Differentiation and M2 Macrophage Polarization by PI3K/AKT/mTOR Pathway in Human Umbilical Cord Mesenchymal Stem Cells. |
Shen, Min; Yu, Huihui; Jin, Yunfeng; Mo, Jiahang; Sui, Jingni; Qian, Xiaohan; Chen, Tong |
|
Jun 18, 2022 |
6246 |
| Nephrologist and haematological malignancies. |
Naqvi, Rubina |
|
Jun 18, 2022 |
1167 |
| Cancer patient left waiting for weeks as tests sent to London; The ECHO understands Liverpool Clinical Laboratories outsources a small amount of tests. |
By, Patrick Edrich |
|
Jun 18, 2022 |
650 |
| Sana presents data at ISSCR 2022 on transplanted allogeneic, hypoimmune cells. |
|
|
Jun 17, 2022 |
398 |
| INmune Bio presents data on combination therapy with INB03. |
|
|
Jun 16, 2022 |
230 |
| new app to help children understand respiratory viruses. |
|
|
Jun 15, 2022 |
401 |
| 'Strengthen your immunity day-by-day'. |
|
|
Jun 14, 2022 |
629 |
| How the experts health-proof their holidays; From dealing with traveller's tum to getting help in an emergency, Natasha Holt asks medics how they stay well while they're abroad.. |
Natasha Holt |
|
Jun 14, 2022 |
637 |
| How the experts health-proof their holidays; From dealing with traveller's tum to getting help in an emergency, Natasha Holt asks medics how they stay well while they're abroad. |
Natasha Holt |
|
Jun 14, 2022 |
623 |
| THE POWER OF FLOWERS; Whether you want to boost your immunity or sleep soundly, our much-loved wildflowers could have the answer, says Monica Cafferky. |
Monica Cafferky |
|
Jun 13, 2022 |
976 |
| Homology Medicines says FDA lifts clinical hold on pheNIX gene therapy trial. |
|
|
Jun 13, 2022 |
189 |
| Pfizer, MorphoSys, Incyte collaborate over Monjuvi/TTI-622 combination. |
|
|
Jun 13, 2022 |
223 |
| Prevalence of Epstein-Barr Virus Infection and Mismatch Repair Protein Deficiency and the Correlation of Immune Markers in Tibetan Patients with Gastric Cancer. |
Shi, Jie; Yang, Xu; Wang, Xinmei; Luo, Yufeng; Zhou, Weixun; Luo, Hanhuan; Bianba, Zhaxi |
Report |
Jun 13, 2022 |
7957 |
| Identification of Biomarkers Associated with Diagnosis of Osteoarthritis Patients Based on Bioinformatics and Machine Learning. |
Liang, Yihao; Lin, Fangzheng; Huang, Yunfei |
|
Jun 13, 2022 |
4201 |
| FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma. |
Shen, Ting; Zhang, Jianying; Wang, Yali; Liu, Binjie |
|
Jun 12, 2022 |
5029 |
| Tumor Microenvironment: Lactic Acid Promotes Tumor Development. |
Gao, Yuting; Zhou, Hao; Liu, Gege; Wu, Junlu; Yuan, Yi; Shang, Anquan |
|
Jun 12, 2022 |
6902 |
| Circulating MMP-12 as Potential Biomarker in Evaluating Disease Severity and Efficacy of Sublingual Immunotherapy in Allergic Rhinitis. |
Zhou, Yandan; Xu, Min; Gong, Wei; Kang, Xiaoming; Guo, Renzhong; Wen, Jie; Zhou, Dinggang |
|
Jun 12, 2022 |
5331 |
| Eledon Pharmaceuticals announces orphan drug designation for tegoprubart. |
|
|
Jun 9, 2022 |
165 |
| Breakthrough in fresh quest for cancer cure. |
|
|
Jun 8, 2022 |
805 |
| Breakthrough for cancer treatment as US drug trial records 'success'. |
REPRESENTATIVE IMAGE |
|
Jun 8, 2022 |
250 |
| World Food Day: Safe, Wholesome Food Key To Good Health - NAFDAC. |
|
|
Jun 8, 2022 |
428 |
| Significance of a Tumor Mutation Burden Gene Signature with Prognosis and Immune Feature of Gastric Cancer Patients. |
Xiang, Li; Lan, Chuan |
|
Jun 8, 2022 |
7040 |
| Rapidly progressive glomerulonephritis in children. |
Khemchand N Moorani, Madiha Aziz and Farhana Amanullah |
|
Jun 8, 2022 |
4462 |
| CEL-SCI presents Phase 3 multikine head & neck cancer data at ASCO. |
|
|
Jun 7, 2022 |
166 |
| New cancer drug 'cures every patient in trial'. |
|
|
Jun 7, 2022 |
357 |
| Talaris Therapeutics presents phase 2 data on FCR001 at ATC. |
|
|
Jun 7, 2022 |
251 |
| NAFDAC ADMONISHES NIGERIANS TO CONSUME SAFE, WHOLESOME FOOD. |
|
|
Jun 7, 2022 |
858 |
| World Food Safety Day: Eat right to avoid drugs, NAFDAC advises. |
|
|
Jun 7, 2022 |
566 |
| Food Safety Day: Nigerians Don't Need Medicines If They Eat Right - NAFDAC Boss. |
|
|
Jun 7, 2022 |
869 |
| The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma. |
He, Chenxi; Zhu, Xinying; Kong, Fanting; Zhang, Xiaochong; Chai, Xiukun; Zou, Chunyan; Zhao, Dongqia |
Report |
Jun 7, 2022 |
7374 |
| LATEST COMPANY NEWS. |
|
|
Jun 7, 2022 |
14193 |
| Apexigen announces publication, presentation on Phase 2 PRINCE trial. |
|
|
Jun 6, 2022 |
244 |
| Prognostic Nutritional Index Predicts Outcome of PD-L1 Negative and MSS Advanced Cancer Treated with PD-1 Inhibitors. |
Zhang, Yan; Jin, Jun; Tang, Min; Li, Ping; Zhou, Li-Na; Du, Yi-Ping; Chen, Min-Bin |
Report |
Jun 6, 2022 |
4681 |
| The Combined Clinical Efficacy and Safety Analysis of Adoptive Immunotherapy with Radiotherapy and Chemotherapy in Non-Small-Cell Lung Cancer: Systematic Review and Meta-Analysis. |
Fan, Zhiming; He, Honggui; Chen, Liqun |
|
Jun 6, 2022 |
4624 |
| Comprehensive Analysis Identifies PI3K/Akt Pathway Alternations as an Immune-Related Prognostic Biomarker in Colon Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitor Treatment. |
Lin, Anqi; Gu, Tianqi; Hu, Xigang; Zhang, Jian; Luo, Peng |
|
Jun 6, 2022 |
9461 |
| Bristol-Myers reports five-year data from Phase 3 CheckMate -227 trial. |
|
|
Jun 6, 2022 |
288 |
| Bristol-Myers reports three-year data from Phase 3 CheckMate -9LA trial. |
|
|
Jun 6, 2022 |
309 |
| Agendia Presents Data at ASCO 2022 Pointing to New Signature ImPrint Immunotherapy Prediction and Expansion of Proprietary Genomic Tests' Utility to Identify Patients Who Will Benefit Most from Specific Treatments. |
|
|
Jun 5, 2022 |
949 |
| Taking action against fruit adulterators. |
|
|
Jun 4, 2022 |
183 |
| ISM Deptt conducts awareness cum immunity booster distribution camp. |
|
|
Jun 3, 2022 |
169 |
| Immunotherapy and Antivascular Targeted Therapy in Patients' Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge. |
Shen, Bairu; Guo, Zi; Huang, Peng; Tan, Minghua; Zhang, Xiaoshen; Lin, Siyao; Song, Changshan |
|
Jun 2, 2022 |
7788 |
| Characterization of m6A Methylation Modification Patterns in Colorectal Cancer Determines Prognosis and Tumor Microenvironment Infiltration. |
Yue, Qingfang; Zhang, Yuan; Wang, Fei; Cao, Fei; Bai, Jun; Duan, Xianglong |
|
Jun 1, 2022 |
8748 |
| Evaluation of LGI1-antibody Encephalitis, a Rare Cause of Limbic Encephalitis, from Diagnosis to Treatment/Limbik Ensefalitin Nadir Bir Nedeni Olan LGI1-antikor Ensefalitinin Tanidan Tedaviye Kadar Degerlendirilmesi. |
Uslusoy, Halil Ibrahim; Dinç, Yasemin; Demir, Aylin Bican |
Clinical report |
Jun 1, 2022 |
894 |
| DcR3 in All Its Aspects/Tum Yonleriyle DcR3. |
Helvaci, Nazli; Caglari, Hifa Gulru; Kural, Alev |
|
Jun 1, 2022 |
9068 |
| 'Masked' cancer drug stealthily trains immune system to kill tumors while sparing healthy tissues, reducing treatment side effects. |
Aslan Mansurov |
|
Jun 1, 2022 |
590 |
| Oncomatryx Receives FDA and AEMPS IND Clearance for OMTX705, a First-in-class Tumor Microenvironment-targeted ADC, to Treat Advanced Solid Tumors. |
|
|
May 31, 2022 |
272 |
| Classification of Muscle Invasive Bladder Cancer to Predict Prognosis of Patients Treated with Immunotherapy. |
Wang, Zhifeng; Li, Xiqing; Wang, Xiaoqing; Liu, Jie; Wang, Lingdian; Wei, Wei; Duan, Xiaoyu |
|
May 30, 2022 |
6734 |
| Bristol-Myers announces FDA approves two Opdivo-based regimens. |
|
|
May 28, 2022 |
157 |
| Cool mountain breeze, fresh pine scent and an abundance of greens only at Alpine Villas. |
|
|
May 28, 2022 |
854 |
| Clinical Factors of Blood Transfusion-Related Acute Lung Injury and Changes in Levels of Treg-Related Cytokines. |
Sun, Lifang; Liu, Yu |
|
May 27, 2022 |
3478 |
| Bolt Biotherapeutics to present ex vivo data on myeloid cell landscape. |
|
|
May 27, 2022 |
177 |
| LintonPharm to Release Data on Catumaxomab for Advanced Gastric Cancer with Peritoneal Metastasis at 2022 ASCO Annual Meeting. |
|
|
May 27, 2022 |
514 |
| OncoCyte presents DetermaIO data at ASCO supporting immunotherapy expansion. |
|
|
May 26, 2022 |
157 |
| Three Prognostic Biomarkers Correlate with Immune Checkpoint Blockade Response in Bladder Urothelial Carcinoma. |
Guo, Ya; Zhang, Yin Bin; Li, Yi; Su, Wang Hui; He, Shan; Pan, Shu Pei; Xu, Kun |
|
May 26, 2022 |
10137 |
| The Feasibility of Percutaneous Dilatational Tracheostomy in Immunosuppressed ICU Patients with or without Thrombocytopenia. |
Angelberger, Marianne; Barnikel, Michaela; Fraccaroli, Alessia; Tischer, Johanna; Antón, Sofía; Pawl |
|
May 26, 2022 |
4687 |
| Mangos-a best source of nutrition to fight heatstroke. |
|
|
May 25, 2022 |
416 |
| Mangoes-a best source of nutrition to fight heatstroke. |
|
|
May 25, 2022 |
416 |
| 5-day polio campaign inaugurated at Sheringal, Upper Dir. |
|
|
May 24, 2022 |
197 |
| GeoVax Labs receives notice of allowance for cancer vaccine patent in China. |
|
|
May 24, 2022 |
175 |
| 5-day polio campaign inaugurated at Sheringal, Upper Dir. |
|
|
May 24, 2022 |
197 |
| Differential Regulation of NK Cell Receptors in Acute Lymphoblastic Leukemia. |
Lee, Le Jie; Hassan, Norfarazieda; Idris, Siti Zuleha; Subbiah, Suresh Kumar; Seow, Heng Fong; Mohta |
|
May 23, 2022 |
9128 |
| Pancancer Analyses Reveal Genomics and Clinical Characteristics of the SETDB1 in Human Tumors. |
Lin, Xin; Xiao, Min; Chen, Zhitao; Ding, Chenchen; Zhang, Ting; Li, Qiyong |
|
May 23, 2022 |
11448 |
| Bidco launches immune-boosting fruit juice. |
|
|
May 23, 2022 |
496 |
| BIDCO Launches Immunity Boosting Fruit Juice. |
|
|
May 23, 2022 |
583 |
| Novel Immunotherapy Developed by City of Hope Could Provide New Treatment Model for SARS-CoV-2 Patients. |
|
|
May 23, 2022 |
592 |
| ImmunityBio Submits Biologics License Application for N-803 Plus BCG for Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma in Situ. |
|
|
May 23, 2022 |
828 |
| Bidco launches immune-boosting fruit juice. |
|
|
May 23, 2022 |
186 |
| Green juice all the way: This healthy drink has more benefits than just weight loss. |
|
|
May 22, 2022 |
471 |
| DC Abbottabad inaugurates 5 day anti-polio drive. |
|
|
May 21, 2022 |
274 |
| DC Abbottabad inaugurates 5-day anti-polio drive. |
|
|
May 21, 2022 |
273 |
| Famotidine (Pepcid) Activates the Vagus Nerve to Reduce Cytokine Storm in COVID-19, New Study Shows. |
|
|
May 20, 2022 |
559 |
| Labcorp Launches Skin Cancer Assay. |
|
|
May 19, 2022 |
155 |
| Labcorp Launches Skin Cancer Assay. |
|
|
May 19, 2022 |
162 |
| Relationship between Patients' Baseline Characteristics and Survival Benefits in Immunotherapy-Treated Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. |
Hu, Xuanbo; Liu, Yafeng; He, Yuxiao; Wang, Zibo; Zhang, Hongyan; Yang, Wei; Lu, Jibin |
|
May 19, 2022 |
8533 |
| Identification of an Inflammatory Response-Related Gene Signature to Predict Survival and Immune Status in Glioma Patients. |
Yan, Zhaoyue; Gao, Yushuai; Yu, Jinliang; Shen, Zhiyuan; Bu, Xingyao |
|
May 18, 2022 |
8996 |
| Identification of an Immune Gene-Based Cisplatin Response Model and CD27 as a Therapeutic Target against Cisplatin Resistance for Ovarian Cancer. |
Guo, Ying; Yang, Na; Li, Gang; Yin, Xiurong; Dong, Lixia |
|
May 18, 2022 |
8578 |
| Targeting the Axl and mTOR Pathway Synergizes Immunotherapy and Chemotherapy to Butylidenephthalide in a Recurrent GBM. |
Liu, Ching-Ann; Harn, Horng-Jyh; Chen, Kuan-Pin; Lee, Jui-Hao; Lin, Shinn-Zong; Chiu, Tsung-Lang |
|
May 18, 2022 |
9300 |
| Career women at 70 percent risk of developing breast cancer than housewives. |
|
|
May 18, 2022 |
592 |
| Avalon GloboCare signs MOU with Lu Daopei Hematology Institute. |
|
|
May 18, 2022 |
221 |
| The Effects of CD73 on Gastrointestinal Cancer Progression and Treatment. |
Sun, Pengcheng; Zheng, Xiao; Li, Xiaodong |
|
May 17, 2022 |
7986 |
| Polio again. |
|
|
May 16, 2022 |
377 |
| Could 'world first' probiotic beer signal a healthy future for the category? – focus. |
James Beeson |
|
May 14, 2022 |
1306 |
| FLG Is a Potential Biomarker of Prognosis and Immunotherapy in Skin Cutaneous Melanoma. |
Wu, Shaobo; Liang, Yuxia; Zang, Qijuan; Xing, Zixuan; Yin, Pan; Sun, Ruifang; Dai, Bingling |
|
May 14, 2022 |
5575 |
| Uganda: bee venom therapy as an alternative medicine. |
|
|
May 13, 2022 |
503 |
| U.S. supports efforts to contain COVID-19, vaccinate people in N. Korea: State Dept. |
|
|
May 13, 2022 |
401 |
| Characterization of Tumor Mutation Burden-Based Gene Signature and Molecular Subtypes to Assist Precision Treatment in Gastric Cancer. |
Wei, Cheng; Li, Minzhe; Lin, Shaofeng; Xiao, Jun |
Report |
May 13, 2022 |
7611 |
| Abrine Elicits Liver Carcinoma Immunity and Enhances Antitumor Efficacy of Immune Checkpoint Blockade by Modulating PD-L1 Signaling. |
Zhang, Shaowu |
|
May 12, 2022 |
5425 |
| Medicenna Therapeutics presents Phase 1/2 ABILITY study data. |
|
|
May 11, 2022 |
211 |
| Business cashes in on growing movement of natural and organic beauty products. |
|
|
May 10, 2022 |
1084 |
| Convicted sex offender dies of respiratory failure while serving sentence at HMP Northumberland; Stewart Mangham was serving a 17-year sentence for sex offences at the Acklington prison for sex when he passed away. |
By, Sophie Brownson |
|
May 8, 2022 |
624 |
| AHCYL1 Is a Novel Biomarker for Predicting Prognosis and Immunotherapy Response in Colorectal Cancer. |
Li, Xubin; Zhang, Mengqiao; Yu, Xue; Xue, Mei; Li, Xiaowei; Ma, Chao; Jia, Wei |
|
May 7, 2022 |
4716 |
| A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer. |
Zhang, Xin; Zhang, Xingda; Li, Guozheng; Hao, Yi; Liu, Lei; Zhang, Lei; Chen, Yihai |
|
May 5, 2022 |
7167 |
| Prognostic Risk Signature and Comprehensive Analyses of Endoplasmic Reticulum Stress-Related Genes in Lung Adenocarcinoma. |
Yang, CaiZhen; Wei, YuHui; Li, WenTao; Wei, JinMei; Chen, GuoXing; Xu, MingPeng; Liu, GuangNan |
|
May 4, 2022 |
8723 |
| Oncorus reports Q1 EPS (69c), consensus (77c). |
|
Financial report |
May 4, 2022 |
161 |
| 5 healthy comfort foods for flu season. |
|
|
May 2, 2022 |
409 |
| Thank you for focusing on our charity! |
|
|
May 2, 2022 |
183 |
| Gilead, Dragonfly Forge Research Collaboration to Develop Natural Killer Cell Engagers in Oncology and Inflammation. |
|
|
May 2, 2022 |
421 |
| 'Having a happy gut with the right mix of bacteria could improve cancer treatments'; A new study looking into melanoma and gut microbiome found that there was a link between the bacteria's composition and response to immunotherapy, says Dr Miriam Stoppard. |
By, Miriam Stoppard |
|
May 1, 2022 |
438 |
| Immunotherapies for Myelodysplastic Syndromes: Current State and Future Developments. |
Deeb, George; Papadanatonakis, Nikolaos |
Report |
May 1, 2022 |
5789 |
| Challenges encountered by human immunodeficiency virus positive pregnant women on taking antiretrovirals in a public health unit of the Manzini region, Swaziland. |
Mbatha, Trusty L.; Habedi, Debbie SK. |
Report |
May 1, 2022 |
5437 |
| The Effects of Immunosuppressive Therapy on Mortality in Patients Followed in Intensive Care Units with the Diagnosis of Critical Coronavirus Disease-2019 Pneumonia. |
Ayten, Omer; Iscanli, Insa Gul Ekiz; Canoglu, Kadir; Kismet, Gozde Kalbaran; Ozdemir, Cengiz; Saylan |
|
May 1, 2022 |
4368 |
| Role of CD4[sup.+]T, CD8[sup.+]T Cells, and CD4[sup.+]T/CD8[sup.+]T Cell Ratio in Gastric Cancer and Its Clinical Significance. |
Han, Jingqi; Zhao, Linglin; Wu, Jianying; Diao, Yinzhuo; Guo, Qijing; Yang, Jie; Luo, Yushuang |
|
Apr 30, 2022 |
6154 |
| NEIL3 Mediates Lung Cancer Progression and Modulates PI3K/AKT/mTOR Signaling: A Potential Therapeutic Target. |
Huang, Hongbo; Hua, Qingwang |
|
Apr 30, 2022 |
5031 |
| Clinical Efficacy of Interventional Chemotherapy Embolization Combined with Monopolar Radiofrequency Ablation on Patients with Liver Cancer. |
Tian, Zhenhua; Zhang, Wei |
|
Apr 29, 2022 |
7179 |
| Cancer patient has 'second chance' at life following ground-breaking treatment; Richard Condie, 64, of Surrey, was given bleak 12-month prognosis in January 2021 but joined immunotherapy trial and now feels fighting fit. |
By, Rikki Loftus (PA) & Brett Gibbons |
|
Apr 29, 2022 |
1156 |
| Family's desperate campaign to fund 'liquid gold' £32k skin cancer treatment; Britt Rhodes, 53, was diagnosed with stage four Melanoma last year and ground-breaking immunotherapy treatment gives her the best chance of normal life. |
By, Charles Gray & Brett Gibbons |
|
Apr 29, 2022 |
523 |
| Cancer patient has 'second chance' at life following ground-breaking treatment; Richard Condie, 64, of Surrey, was given bleak 12-month prognosis in January 2021 but joined immunotherapy trial and now feels fighting fit. |
By, Rikki Loftus (PA) & Brett Gibbons |
|
Apr 29, 2022 |
1156 |
| Cancer patient has 'second chance' at life following ground-breaking treatment; Richard Condie, 64, of Surrey, was given bleak 12-month prognosis in January 2021 but joined immunotherapy trial and now feels fighting fit. |
By, Rikki Loftus (PA) & Brett Gibbons |
|
Apr 29, 2022 |
1156 |
| Cancer patient has 'second chance' at life following ground-breaking treatment; Richard Condie, 64, of Surrey, was given bleak 12-month prognosis in January 2021 but joined immunotherapy trial and now feels fighting fit. |
By, Rikki Loftus (PA) & Brett Gibbons |
|
Apr 29, 2022 |
1156 |
| Family's desperate campaign to fund 'liquid gold' £32k skin cancer treatment; Britt Rhodes, 53, was diagnosed with stage four Melanoma last year and ground-breaking immunotherapy treatment gives her the best chance of normal life. |
By, Charles Gray & Brett Gibbons |
|
Apr 29, 2022 |
523 |
| Cancer patient has 'second chance' at life following ground-breaking treatment; Richard Condie, 64, of Surrey, was given bleak 12-month prognosis in January 2021 but joined immunotherapy trial and now feels fighting fit. |
By, Rikki Loftus (PA) & Brett Gibbons |
|
Apr 29, 2022 |
1156 |
| Cancer patient has 'second chance' at life following ground-breaking treatment; Richard Condie, 64, of Surrey, was given bleak 12-month prognosis in January 2021 but joined immunotherapy trial and now feels fighting fit. |
By, Rikki Loftus (PA) & Brett Gibbons |
|
Apr 29, 2022 |
1156 |
| IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer. |
Li, Guangyao; Wang, Yandong; Cheng, Ya |
|
Apr 29, 2022 |
7025 |
| Different In Situ Immune Patterns between Primary Tumor and Lymph Node in Non-Small-Cell Lung Cancer: Potential Impact on Neoadjuvant Immunotherapy. |
Ye, Zheng-Hao; Long, Hao; Zhao, Ze-Rui |
|
Apr 28, 2022 |
7617 |
| Single-Cell Sequencing Analysis Based on Public Databases for Constructing a Metastasis-Related Prognostic Model for Gastric Cancer. |
Xu, Rubin; Chen, Liang; Wei, Wei; Tang, Qikai; Yu, You; Hu, Yiming; Kadasah, Sultan |
|
Apr 27, 2022 |
6840 |
| Necroptosis-Associated lncRNA Prognostic Model and Clustering Analysis: Prognosis Prediction and Tumor-Infiltrating Lymphocytes in Breast Cancer. |
Tao, Shigui; Tao, Kunlin; Cai, Xiaoyong |
|
Apr 27, 2022 |
6488 |
| Around 2,100 immunocompromised individuals get 2nd booster shot vs COVID-19 - DOH. |
|
|
Apr 27, 2022 |
205 |
| Comprehensive Analysis of RAPGEF2 for Predicting Prognosis and Immunotherapy Response in Patients with Hepatocellular Carcinoma. |
Wu, Qing; Hu, Yangzhi; Ma, Qinghui; Yang, Shanglin; Chen, Junpeng; Wen, Shunqian; Liao, Guanqun |
|
Apr 26, 2022 |
7830 |
| Working to reform diabetes treatment; CONDITION COULD EVEN BE CURED THANKS TO RESEARCH. |
SAM VOLPE Reporter sam.volpe@reachplc.com |
|
Apr 26, 2022 |
567 |
| Research offers fresh hope for Type 1 diabetics. |
SAM VOLPE Reporter |
|
Apr 26, 2022 |
590 |
| circ-0007707/miR-429/PDGFD Pathway Regulates the Progression of Gastric Cancer by Modulating the Immune-Gene Signature. |
Yang, Yang; Kang, Weibiao; Yuan, Yu; Duan, Chen; Chen, Wei; Yu, Changjun |
|
Apr 25, 2022 |
6845 |
| Newcastle expert hopes new drug trial could lead way to potential cure for Type 1 Diabetes; Dr Nicola Leech at the Newcastle Hospitals NHS Trust is hopeful that the a new study could changes the lives of people newly-diagnosed with Type 1 Diabetes. |
By, Sam Volpe |
|
Apr 25, 2022 |
624 |
| Head and Neck Squamous Cell Carcinoma: NT5E Could Be a Prognostic Biomarker. |
Zhang, Yaoting; Kadasah, Sultan; Xie, Jiaheng; Gu, Dongsheng |
|
Apr 25, 2022 |
4939 |
| Health Ministry working on Covid-19 action plan for fall. |
|
|
Apr 23, 2022 |
153 |
| Immune-Onc Therapeutics Selects Clinical Development Candidate IO-106, a First-in-Class Myeloid and Stromal Checkpoint Inhibitor Targeting LAIR1. |
|
|
Apr 22, 2022 |
623 |
| HCW Biologics CEO to be featured speaker at CEB-2022. |
|
|
Apr 19, 2022 |
415 |
| Considering Computational Mathematics IGHG3 as Malignant Melanoma Is Associated with Immune Infiltration of Malignant Melanoma. |
Si, Mengqing; Cao, Xianwei |
Report |
Apr 18, 2022 |
7508 |
| Immunotherapy Mechanism of Esophageal Squamous Cell Carcinoma with the Effect of STK11/AMPK Signaling Pathway. |
Xia, Yang; Wang, Peng; Ye, Yunyao; Zhang, Sihui; Sun, Guangzhi; Xu, Jie; Han, Gaohua |
Report |
Apr 15, 2022 |
5223 |
| Dissection of Immune Profiles in Microsatellite Stable and Low Microsatellite Instability Colon Adenocarcinoma by Multiomics Data Analysis. |
Yang, Tao; Lei, Jiali; Feng, Qiushi; Song, Dandan; Wang, Xiaosheng |
|
Apr 15, 2022 |
11502 |
| Construction of a miRNA Signature Using Support Vector Machine to Identify Microsatellite Instability Status and Prognosis in Gastric Cancer. |
Wang, Ya-nan; Wei, Ya-ning; Fan, Xiang-yu; Xu, Fang; Dong, Zheng-yang; Cheng, Shu-jie; Zhang, Jin-ku |
|
Apr 15, 2022 |
3514 |
| Novel Covid vax may provide protection for cancer patients. |
|
|
Apr 14, 2022 |
386 |
| Novel Covid vax may provide protection for cancer patients. |
|
|
Apr 14, 2022 |
386 |
| Diamyd Medical AB announces clinical trial of Diamyd booster in diabetes patients. |
|
|
Apr 14, 2022 |
181 |
| Diamyd Medical AB announces clinical trial of Diamyd booster in diabetes patients. |
|
|
Apr 14, 2022 |
179 |
| Diamyd Medical AB announces clinical trial of Diamyd booster in diabetes patients. |
|
|
Apr 14, 2022 |
180 |
| Fasting boosts immunity, regulates blood sugar levels and improves general health, says expert. |
|
|
Apr 14, 2022 |
568 |
| Health benefits of simply being happy. |
|
|
Apr 13, 2022 |
463 |
| 2.3 million people to get cholera vaccine. |
|
|
Apr 13, 2022 |
533 |
| Hookipa Pharma announces preclinical data on arenaviral immunotherapies. |
|
|
Apr 13, 2022 |
499 |
| Inhibition of PARP Potentiates Immune Checkpoint Therapy through miR-513/PD-L1 Pathway in Hepatocellular Carcinoma. |
Sun, Guoqiang; Miao, Ganggang; Li, Zhitao; Zheng, Wubin; Zhou, Chunguang; Sun, Guangshun; Cao, Hongy |
|
Apr 13, 2022 |
5819 |
| Development an Immune-Related MicroRNA Risk Index in Hepatocellular Carcinoma. |
Zhou, Shun; Xu, Jian; Wang, Dong; Wang, Yong; Meng, Lijuan |
|
Apr 12, 2022 |
5319 |
| Prediction of Prognosis and Recurrence of Bladder Cancer by ECM-Related Genes. |
Zhao, Hongfan; Chen, Zihao; Fang, Yunze; Su, Mingqiang; Xu, Yipeng; Wang, Zhifeng; Gyamfi, Michael A |
|
Apr 12, 2022 |
8722 |
| Alpine Immune Sciences says feasible to engage CD28 for cancer immunotherapy. |
|
|
Apr 12, 2022 |
262 |
| Caerin 1 Peptides, the Potential Jack-of-All-Trades for the Multiple Antibiotic-Resistant Bacterial Infection Treatment and Cancer Immunotherapy. |
Xiao, Liyin; Yang, Xiaodan; Li, Junjie; Zhang, Pingping; Tang, Shuxian; Cao, Dongmin; Chen, Shu |
Report |
Apr 11, 2022 |
9880 |
| Advaxis announces publication of ADXS-PSA in The Oncologist. |
|
|
Apr 8, 2022 |
235 |
| Medicenna Therapeutics announces preclinical data on BiSKIT. |
|
|
Apr 8, 2022 |
290 |
| Oncorus presents preclinical data on ONCR-021, ONCR-788. |
|
|
Apr 8, 2022 |
396 |
| Agenus presents preclinical data on AGEN1571 at AACR meeting. |
|
|
Apr 8, 2022 |
192 |
| Adagene announces preclinical data on antibody candidates. |
|
|
Apr 8, 2022 |
609 |
| Protective Prognostic Biomarkers Negatively Correlated with Macrophage M2 Infiltration in Low-Grade Glioma. |
Zhu, Yunyang; Song, Zhaoming; Wang, Zhong; Chen, Gang |
|
Apr 8, 2022 |
6191 |
| Clinical curative effect of neoadjuvant chemotherapy combined with immunotherapy and its impact on immunological function and the expression of ER, PR, HER-2 and SATB1 in HER-2-Positive breast cancer patients. |
Zhi Chen, Mei-xiang Sang, Cui-zhi Geng, Wei Hao and Hui-qun Jia |
|
Apr 8, 2022 |
3157 |
| BriaCell advances preparatory work for new Bria-OTS breast cancer trial. |
|
|
Apr 7, 2022 |
231 |
| Economic burden of non-communicable diseases in Nigeria (III). |
|
|
Apr 6, 2022 |
800 |
| Yong invites children to participate in clinical study with Pfizer as third dose. |
|
Clinical report |
Apr 6, 2022 |
211 |
| HDT Bio Demonstrates RNA Vaccines Matched to SARS-CoV2 Variants Protect Against Infection of Upper Airways, Important for Preventing Transmission. |
|
|
Apr 6, 2022 |
480 |
| Prognosis and Characterization of Immune Microenvironment in Head and Neck Squamous Cell Carcinoma through a Pyroptosis-Related Signature. |
Lu, Lin; Zhang, Peiling; Cao, Xiaofei; Guan, Mingmei |
|
Apr 6, 2022 |
7371 |
| Bristol-Myers receives EC approval for Opdivo as immunotherapy option. |
|
|
Apr 5, 2022 |
175 |
| Tonix extends sponsored research agreement with Kansas State University. |
|
|
Apr 5, 2022 |
257 |
| INmune Bio highlights INKmune data in NK Cells in Solid Tumors workshop. |
|
|
Apr 4, 2022 |
275 |
| The foods you should never eat just before bed if you want a better night's sleep from crisps to sweets; There are lots of healthy options for snacks before bedtime to help you rest easy. |
By, Lucy Williamson |
|
Apr 2, 2022 |
971 |
| Bordetella hinzii Pneumonia in Patient with SARS-CoV-2 Infection. |
Lakhal, Hend Ben; Cachinho, Jose Bras; Kalfon, Pierre; Naas, Thierry; Benseddik, Zehaira |
Clinical report |
Apr 1, 2022 |
2489 |
| ImmunityBio Closes USD 470m Post-merger Financing to Fund Late-stage Cancer Clinical Trials, Phase 3 of COVID T-Cell Universal Boost Vaccine Trial and Provides Update on Bladder Cancer BLA Filing. |
|
|
Apr 1, 2022 |
1400 |
| MAIT cells may be key to the next wave of immunotherapy and vaccine development. |
|
|
Apr 1, 2022 |
323 |
| WHO says most likely scenario shows COVID severity will decrease over time. |
|
|
Apr 1, 2022 |
192 |
| Retrospective Evaluation of Risk Factors for the Development of Invasive Fungal Infections in Immunosuppressed Patients/Immunsuprese Hastalarda Invaziv Fungal Enfeksiyon Gelisimindeki Risk Faktorlerinin Retrospektif Degerlendirilmesi. |
Ozalp, Onur; Yesilkaya, Aysegul; Ok, Mehtap Akcil; Arslan, Ayse Hande |
Report |
Apr 1, 2022 |
4982 |
| Rare Cause of Anuria in a Patient with Horseshoe Kidney. |
Singh, Shailendra; Beniwal, Pankaj; Gaur, Nisha; Sharma, Manish; Rathore, Vinay; Malhotra, Vinay |
|
Apr 1, 2022 |
1728 |
| A comparison of rituximab with cyclophosphamide in terms of efficacy and complications as induction therapy for treating granulomatosis with polyangiitis: A three-center study. |
Chaleshtori, Maryam Tavakoli; Farajzadegan, Ziba; Salesi, Mansour |
Report |
Apr 1, 2022 |
3171 |
| Understanding of Immune Escape Mechanisms and Advances in Cancer Immunotherapy. |
Aktar, Nasrin; Yueting, Chen; Abbas, Muhammad; Zafar, Hajra; Paiva-Santos, Ana Cláudia; Zhang, Qin; |
|
Mar 31, 2022 |
11813 |
| Cidara announces completion of dosing of healthy volunteers in Phase 1 trial. |
|
|
Mar 31, 2022 |
249 |
| Replimune Group provides overview of RP 2/3 Phase 2 development plans. |
|
|
Mar 30, 2022 |
202 |
| Microvascular Invasion in Hepatocellular Carcinoma: A Review of Its Definition, Clinical Significance, and Comprehensive Management. |
Zheng, Zehao; Guan, Renguo; Jianxi, Wang; Zhao, Zhen; Peng, Tianyi; Liu, Chunsheng; Lin, Ye |
|
Mar 30, 2022 |
9749 |
| Analysis of the Heterogeneity of the Tumor Microenvironment and the Prognosis and Immunotherapy Response of Different Immune Subtypes in Hepatocellular Carcinoma. |
Hu, Jian; Mao, Feifei; Li, Lifang; Wang, Xiaoqian; Cai, Depei; He, Longmei; Wu, Qian |
|
Mar 29, 2022 |
9290 |
| Aspirin Suppressed PD-L1 Expression through Suppressing KAT5 and Subsequently Inhibited PD-1 and PD-L1 Signaling to Attenuate OC Development. |
Xiao, Xiyun; Zeng, Saitian; Li, Yanying; Li, Lingling; Zhang, Jiyan |
|
Mar 29, 2022 |
4124 |
| HDT Bio Doses First Healthy Volunteer in US Phase 1 Trial of Next Generation COVID-19 Variant RNA Vaccine. |
|
|
Mar 29, 2022 |
465 |
| Good sleep helps boost immune system. |
|
|
Mar 29, 2022 |
689 |
| CytoImmune Therapeutics Opens Clinical Cell Manufacturing Facility in Toa Baja. |
|
|
Mar 28, 2022 |
222 |
| The Role of PDGFRA in Predicting Oncological and Immune Characteristics in Pancreatic Ductal Adenocarcinoma. |
Wu, Zijian; Xu, Jin; Tang, Rong; Wang, Wei; Zhang, Bo; Yu, Xianjun; Liu, Jiang |
|
Mar 26, 2022 |
7705 |
| Characterization of Aging-Related Genes to Predict Prognosis and Evaluate the Tumor Immune Microenvironment in Malignant Melanoma. |
Zeng, Ni; Guo, Chenrui; Wang, Yajun; Li, Lin; Chen, Xi; Gao, Shaoying; Jiang, Feng |
|
Mar 24, 2022 |
6784 |
| Hookipa Pharma reports Q4 EPS (65c), consensus (58c). |
|
Financial report |
Mar 24, 2022 |
171 |
| The Aluth Pola Fundraiser for Justice for Animals. |
|
|
Mar 23, 2022 |
274 |
| Identify a DNA Damage Repair Gene Signature for Predicting Prognosis and Immunotherapy Response in Cervical Squamous Cell Carcinoma. |
Zhou, Hong; Wu, Limei; Yu, Lijun; Yang, Yabing; Kong, Lili; Liu, Shuo; Chen, Wenhui |
|
Mar 23, 2022 |
6030 |
| KIF26B in the Prognosis and Immune Biomarking of Various Cancers: A Pan-Cancer Study. |
Sun, Fei; Lian, Yingying; Wang, Jianlin; Hu, Lijun; Luo, Judong; Yu, Jingping |
|
Mar 22, 2022 |
4857 |
| Mortality Associated with Recurrent Extreme Hyperferritinemia in Critically Ill Adolescents. |
Baird, John Scott |
|
Mar 22, 2022 |
3857 |
| GeoVax Labs announces issuance of cancer vaccine patent. |
|
|
Mar 22, 2022 |
203 |
| Bristol Myers sues AstraZeneca over cancer drug patents. |
|
|
Mar 19, 2022 |
234 |
| S100A8 as a Promising Biomarker and Oncogenic Immune Protein in the Tumor Microenvironment: An Integrative Pancancer Analysis. |
Wu, Zixuan; Jiang, Dongli; Huang, Xuyan; Cai, Minjie; Yuan, Kai; Huang, Peidong |
|
Mar 18, 2022 |
5286 |
| Recent Advances and Next Breakthrough in Immunotherapy for Cancer Treatment. |
Yang, Ling; Ning, Qian; Tang, Sheng-song |
|
Mar 18, 2022 |
9046 |
| A Novel Immune-Related Prognostic Signature Predicting Survival in Patients with Pancreatic Adenocarcinoma. |
Zhang, Xiao; Li, Xiaomian; Xie, Jun; Zhu, Qian; Yuan, Yufeng |
|
Mar 18, 2022 |
11156 |
| Analysis of a Systemic Inflammatory Biomarker in Advanced Bile Tract Carcinoma Treated with Anti-PD-1 Therapy: Prognostic and Predictive Significance of Lung Immune Prognostic Index Score. |
Pan, Yuting; Si, Hanyan; Jia, Ru; Deng, Guochao; Yan, Huan; Fan, Mengjia; Gou, Miaomiao |
|
Mar 17, 2022 |
7969 |
| China CDE Approved First Universal CAR-T IND. |
|
|
Mar 17, 2022 |
274 |
| People can visit hometowns for Songkran: Anutin. |
|
|
Mar 16, 2022 |
223 |
| Werewolf Therapeutics announces publication of data on WTX-124. |
|
|
Mar 16, 2022 |
266 |
| New cancer centre offers cutting-edge treatment. |
|
|
Mar 15, 2022 |
706 |
| Durvalumab as Consolidation Therapy in Post-Multimodal Interventional Treatment for Patients with Advanced Solid Tumors: A Preliminary Study. |
Li, Yuanming; Guo, Runqi |
Report |
Mar 15, 2022 |
6295 |
| The future of God: speaking in tongues boosts the immune system. |
|
|
Mar 13, 2022 |
1724 |
| Foods To Boost Your Immune System. |
|
|
Mar 13, 2022 |
505 |
| The Detection and Verification of Two Heterogeneous Subgroups and a Risk Model Based on Ferroptosis-Related Genes in Hepatocellular Carcinoma. |
Li, Jiang; Tao, Haisu; Wang, Wenqiang; Li, Jian; Zhang, Erlei |
|
Mar 12, 2022 |
7455 |
| Need to vaccinate 750,000 people daily to meet target: ministry. |
|
|
Mar 11, 2022 |
337 |
| 7 Surprising benefits of vitamin C serum on your skin. |
|
|
Mar 11, 2022 |
535 |
| Uncovering the Immune Cell Infiltration Landscape in Low-Grade Glioma for Aiding Immunotherapy. |
Yang, Youyuan; Tian, Yue; Li, Qing; Jiang, Rui; Zhang, Junfeng |
|
Mar 11, 2022 |
6421 |
| Need to vaccinate 750,000 people daily to meet target: ministry. |
|
|
Mar 11, 2022 |
332 |
| Why Is garlic healthy for you? |
By: Articlecity |
|
Mar 9, 2022 |
889 |
| First Patient Dosed in Phase 1/2 Study of Lead Glyco-Immunology Drug Candidate for Oncology. |
|
|
Mar 9, 2022 |
260 |
| Epidemic kills 54 cattle, infects over 20,000. |
|
|
Mar 9, 2022 |
470 |
| Aravax Pty Opens US IND for Phase 2 clinical trials of PVX108 Immunotherapy for the Treatment of Peanut Allergy. |
|
|
Mar 7, 2022 |
326 |
| Caritas Philippines partners with Ceelin to boost immunity protection of Filipino children. |
|
|
Mar 7, 2022 |
644 |
| Reasons a good relationship will slip out of your hands. |
|
|
Mar 5, 2022 |
865 |
| Boost your immunity and fight inflammation with two new herbal QminC drinks. |
|
|
Mar 4, 2022 |
729 |
| Renowned virologist says people will continue to need vaccine jabs for long-term high immunity against COVID-19. |
|
|
Mar 4, 2022 |
385 |
| Application of m[sup.6]A and TME in Predicting the Prognosis and Treatment of Clear Cell Renal Cell Carcinoma. |
Pei, Dongchen; Xu, Chaojie; Wang, Dong; Shi, Xiaoxue; Zhang, Yurui; Liu, Yi; Liu, Nan |
|
Mar 4, 2022 |
8816 |
| Associations of Clinical and Molecular Characteristics with the Response to Immune Checkpoint Blockade in Advanced Gastric Cancers. |
Xu, Xiaoqing; Li, Jingjing; Gao, Yiding; Lv, Wangxia; Wei, Qing; Tang, Xiaowan; Hu, Jinlin |
|
Mar 4, 2022 |
6126 |
| Optimizing the Method for Differentiation of Macrophages from Human Induced Pluripotent Stem Cells. |
Li, Shanshan; Song, Lili; Zhang, Yingwen; Zhan, Zhiyan; Yang, Yi; Yu, Lisha; Zhu, Hua |
|
Mar 3, 2022 |
6906 |
| Prokarium Exercises Option for an Exclusive Worldwide License for the Use of Salmonella Immunotherapy in the Treatment of Bladder Cancer. |
|
|
Mar 2, 2022 |
386 |
| The Return to Wellness. |
|
|
Mar 2, 2022 |
1085 |
| Cytokine-cytokine receptor interactions in the highly pathogenic avian influenza H5N1 virus-infected lungs of genetically disparate Ri chicken lines. |
Vu, Thi Hao; Hong, Yeojin; Truong, Anh Duc; Lee, Jiae; Lee, Sooyeon; Song, Ki- Duk; Cha, Jihye; Dang |
Report |
Mar 1, 2022 |
4990 |
| Healthy gut bacteria helps fight cancer. |
|
|
Mar 1, 2022 |
165 |
| Oxford BioDynamics Launches Checkpoint Inhibitor Response Test for Oncology in US Market. |
|
|
Mar 1, 2022 |
652 |
| The Effect of Massage on Salivary Secretory Iga Level in Preterm Infants. |
Karamian, Armin; Firouzi, Majid; Modiri, Roshanak; Karamian, Amin |
Report |
Mar 1, 2022 |
4017 |
| The assessment of rheumatologic immune-related adverse events with immune checkpoint inhibitors. |
Tekgoz, Emre; Colak, Seda; Acar, Ramazan; Erturk, Ismail; Aykan, Musa Baris; Yildiz, Birol; Karadurm |
Clinical report |
Mar 1, 2022 |
3907 |
| Chordoma: A Review and Differential Diagnosis. |
Ulici, Veronica; Hart, Jesse |
Report |
Mar 1, 2022 |
7441 |
| Hastanemizdeki Farkli Hasta Gruplarinda Toxoplasma gondii Seroprevalansi/Seroprevalence of Toxoplasma gondii in Different Patient Groups in Our Hospital. |
Tasbent, Fatma Esenkaya; Beder, Duygu; Ozdemir, Mehmet; Dogan, Metin; Feyzioglu, Bahadir |
|
Mar 1, 2022 |
4410 |
| Medicinal mushrooms (specifically Ganoderma lucidum or Reishi) as an adjuvant treatment in breast cancer. |
Lilburn, Catherine |
|
Mar 1, 2022 |
5236 |
| Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy. |
Yanik, Ozge; Batioglu, Figen; Yalcindag, Nilufer; Demirel, Sibel; Ozmert, Emin |
|
Mar 1, 2022 |
1835 |
| Evaluation of COVID-19 Cases Who Received Immunosuppressive Therapy at a Tertiary Care Hospital/Ucuncu Basamak Bir Hastanede Takip Edilen COVID- 19 Olgularinda Immunosupresif Tedavi Uygulanan Hastalarin Degerlendirilmesi. |
Sayar, Merve Sefa; Acar, Ali; Bulut, Dilek; Celik, Sebahattin; Oguz, Emin |
|
Mar 1, 2022 |
5212 |
| The Pandemic Spurs an Ever-Increasing Demand for Wellness Teas. |
Kiel, Aaron |
|
Mar 1, 2022 |
2172 |
| Primary cutaneous lymphomas and Coronavirus disease-2019: A critical overview of primary cutaneous lymphoma management in pandemic/Primer kutanoz lenfomalar ve Koronavirus hastaligi-2019: Pandemide primer kutanoz lenfoma yonetiminin gozden gecirilmesi. |
Ornek, Sinem; Bilgic, Asli; Yazici, Serkan; Bayramgurler, Dilek; Sanli, Hatice; Onsun, Nahide |
Disease/Disorder overview |
Mar 1, 2022 |
4363 |
| Is Having Inflammatory Bowel Disease a Risk Factor for Severe Acute Respiratory Syndrome Coronavirus 2? |
Cavus, Bilger; Akyuz, Filiz; Cifcibasi, Asli Ormeci; Ozgur, Ilker; Erel, Cansu; Yakut, Aysun; Imanov |
Report |
Mar 1, 2022 |
5689 |
| Is Having Inflammatory Bowel Disease a Risk Factor for Severe Acute Respiratory Syndrome Coronavirus 2? |
Cavus, Bilger; Akyuz, Filiz; Cifcibasi, Asli Ormeci; Ozgur, Ilker; Erel, Cansu; Yakut, Aysun; Imanov |
|
Mar 1, 2022 |
5690 |
| Fatal septic shock caused by Capnocytophaga canimorsus diagnosed by 16S rRNA gene sequencing. |
Bergon, Ludovic; Foissac, Maud; Riviere, Brigitte; Steinbach, Marie Isabelle; Catala, Bob; Khatibi, |
Clinical report |
Mar 1, 2022 |
2290 |
| Correlation between Tumor Microenvironment and Immune Subtypes Based on CD8 T Cells Enhancing Personalized Therapy of Gastric Cancer. |
Wu, Jianyu; Xiao, Yajie; Lu, Weiqi; Zhang, Zijing; Yang, Haigan; Cui, Xiaoli; Wu, Dongfang |
|
Feb 28, 2022 |
10689 |
| China's regulator accepts supplemental New Drug Application for JW Therapeutics' Carteyva. |
|
|
Feb 28, 2022 |
170 |
| China's regulator accepts supplemental New Drug Application for JW Therapeutics' Carteyva. |
|
|
Feb 28, 2022 |
169 |
| City of Hope, Osel Say Live Biotherapeutic Product CBM588 May Enhance Efficacy of Immunotherapy for Patients with Metastatic Kidney Cancer. |
|
|
Feb 28, 2022 |
385 |
| Anti-polio drive begins in Punjab. |
|
|
Feb 27, 2022 |
444 |
| Covid: Campaign to vaccinate 10 million people in a day underway. |
|
|
Feb 26, 2022 |
285 |
| 5 benefits of eating dates in the morning. |
|
|
Feb 26, 2022 |
226 |
| EXERCISING AFTER A VACCINE MAY SAFELY BOOST ANTIBODIES. |
|
|
Feb 26, 2022 |
823 |
| Business registrations highest in 10 years. |
|
|
Feb 25, 2022 |
269 |
| Four locally made Covid-19 vaccines may be ready for public use by 2023. |
|
|
Feb 23, 2022 |
469 |
| Task force to focus on house-to-house, mobile COVID-19 vaccination to jab more people. |
|
|
Feb 22, 2022 |
287 |
| Immune-Onc Therapeutics Receives FDA Fast Track Designation for IO-202, the First Anti-LILRB4 Myeloid Checkpoint Inhibitor, for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia. |
|
|
Feb 22, 2022 |
669 |
| Get an immunity boost at Vivid by Verita Health. |
|
|
Feb 21, 2022 |
433 |
| Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway. |
Guangshun, Sun; Guoqiang, Sun; Xin, Chen; Xiangyi, Kong; Wubin, Zheng; Zhitao, Li; Zhiying, Zheng |
|
Feb 21, 2022 |
5026 |
| Defining Diffuse Large B-Cell Lymphoma Immunotypes by CD8+ T Cells and Natural Killer Cells. |
Qi, Jing; Xu, Lu; Huang, Dongping; He, Hesheng; Yao, Junping; Zhang, Jing; Xu, Youhai |
|
Feb 21, 2022 |
6730 |
| Long Noncoding RNA TUG1 Inhibits Tumor Progression through Regulating Siglec-15-Related Anti-Immune Activity in Hepatocellular Carcinoma. |
Ren, Yanyi; Lyu, Jiayi; Guo, Yaoguang; Yao, Yuan; Hu, Lin |
|
Feb 21, 2022 |
7812 |
| China allows Covid boosters of different technologies than primary shots. |
Reuters News Service |
|
Feb 19, 2022 |
388 |
| Journal of Allergy and Clinical Immunology Publishes Pooled Safety Analysis of Palforzia Treatment for up to 2 Years in the Journal of Allergy and Clinical Immunology. |
|
|
Feb 18, 2022 |
237 |
| Current Status of Malignant Tumors after Organ Transplantation. |
Shen, Bairu; Cen, Zhuofei; Tan, Minghua; Song, Changshan; Wu, Xuhui; Wang, Jiaqing; Huang, Minqian |
Report |
Feb 18, 2022 |
9999 |
| Development of a Novel Immune Subtyping System Expanded with Immune Landscape and an 11-Gene Signature for Predicting Prostate Cancer Survival. |
Li, Nan; Yu, Kai; Lin, Zhong; Zeng, Dingyuan |
|
Feb 16, 2022 |
6160 |
| Anambra Library Director, Udeze makes case for organic foods. |
|
|
Feb 16, 2022 |
455 |
| Pan-Cancer Analysis of Microfibrillar-Associated Protein 2 (MFAP2) Based on Bioinformatics and qPCR Verification. |
Qiu, Zhilei; Xin, Miao; Wang, Chenyang; Zhu, Yueli; Kong, Qingnuan; Liu, Zhijun |
|
Feb 15, 2022 |
6373 |
| Signature of m5C-Related lncRNA for Prognostic Prediction and Immune Responses in Pancreatic Cancer. |
Liu, Xiangrong; Wang, Dan; Han, Shiyu; Wang, Fang; Zang, Jinfeng; Xu, Caifeng; Dong, Xue |
|
Feb 15, 2022 |
5461 |
| Israel to offer AstraZeneca's antibody cocktail to the immunocompromised. |
|
|
Feb 15, 2022 |
174 |
| Israel to offer AstraZeneca's antibody cocktail to the immunocompromised. |
|
|
Feb 15, 2022 |
173 |
| Identification of Potential Immune Checkpoint Inhibitor Targets in Gliomas via Bioinformatic Analyses. |
Ding, Mengmeng; Li, Yong-an; Lu, Zhimin; Hou, Guoxin |
Report |
Feb 14, 2022 |
6669 |
| Comprehensive Analysis of a Novel Lipid Metabolism-Related Gene Signature for Predicting the Prognosis and Immune Landscape in Uterine Corpus Endometrial Carcinoma. |
Tan, Xiaofang; Liu, Shuang; Yao, Liangyu; Cui, Guoliang; Liu, Jinhui; Ding, Jiayi |
|
Feb 12, 2022 |
8685 |
| Tipco launches immunity boosting drinks to fight Covid-19. |
|
|
Feb 12, 2022 |
344 |
| Management and Outcomes of ANCA-Associated Vasculitis at a Tertiary Healthcare Facility. |
Moollan, Nabeehah; Ahmed, Adeel Rafi; Denton, Mark |
|
Feb 11, 2022 |
4424 |
| New breast cancer drug 'could save thousands of lives'. |
|
|
Feb 10, 2022 |
188 |
| New drug treatment for breast cancer. |
|
|
Feb 10, 2022 |
201 |
| Evolution of cancer treatment in Kenya and East Africa. |
|
|
Feb 10, 2022 |
720 |
| Identification of Potential Biomarkers of Type 2 Diabetes Mellitus-Related Immune Infiltration Using Weighted Gene Coexpression Network Analysis. |
Zhou, Ji; Zhang, Xiaoyi; Ji, Lixia; Jiang, Guohui |
Report |
Feb 9, 2022 |
6589 |
| UM RESEARCH TEAM DEVELOPS NOVEL METAL-PHENOLIC NETWORK. |
|
|
Feb 8, 2022 |
312 |
| BostonGene Expands Testing Capabilities to Predict Patient Response to Immunotherapy. |
|
|
Feb 8, 2022 |
415 |
| Homeopathic, other natural products grow in appeal. |
|
|
Feb 7, 2022 |
443 |
| Identification and Validation of a Hypoxia-Immune-Based Prognostic mRNA Signature for Oral Squamous Cell Carcinoma. |
Lv, Shaohua; Qian, Zhipeng; Li, Jianhao; Piao, Songlin; Li, Jichen |
|
Feb 7, 2022 |
7670 |
| Understanding the Critical Role of Glycolysis-Related lncRNAs in Lung Adenocarcinoma Based on Three Molecular Subtypes. |
Cao, Peng; Zhao, Bo; Xiao, Yajie; Hu, Shan; Kong, Kangle; Han, Peng; Yue, Jiaqi |
Report |
Feb 7, 2022 |
8638 |
| Prognostic and Immunological Roles of MMP-9 in Pan-Cancer. |
Zeng, Yudan; Gao, Mengqian; Lin, Dongtao; Du, Guoxia; Cai, Yongming |
Report |
Feb 7, 2022 |
6932 |
| Establishment and External Validation of a Hypoxia-Derived Gene Signature for Robustly Predicting Prognosis and Therapeutic Responses in Glioblastoma Multiforme. |
Wang, Ke; Lu, Yang; Liu, Zhihong; Diao, Min; Yang, Lin |
Report |
Feb 4, 2022 |
7692 |
| Newcastle search for lung condition patients to trial treatment which could fight off Covid in the vulnerable; People with COPD and Bronchiestasis are especially vulnerable to Covid-19. But a new Newcastle NHS trial is looking for volunteers with the condition to test a new treatment which could help. |
By, Sam Volpe |
|
Feb 4, 2022 |
323 |
| Tevogen Bio Touts Positive Safety Data from Second Cohort in Ongoing Proof-of-Concept Clinical Trial of TVGN-489, its Investigational T cell Therapy for Treatment of COVID-19 in High-Risk Patients. |
|
|
Feb 3, 2022 |
381 |
| Sidra Medicine study indicates fasting as new immunotherapy for cancer treatment. |
|
|
Feb 3, 2022 |
551 |
| 500,000 people in KP to be vaccinated against corona on a daily basis: DG Health. |
|
|
Feb 3, 2022 |
169 |
| Tegaserod Maleate Inhibits Breast Cancer Progression and Enhances the Sensitivity of Immunotherapy. |
Li, Xiao; Wu, Liangliang; Zheng, Zhiying; Liu, Hanyuan; Li, Haiyang; Sun, Guoqiang; Sun, Guangshun |
|
Feb 3, 2022 |
4649 |
| NCOC launches door to door campaign to vaccinate people against COVID-19. |
|
|
Feb 2, 2022 |
213 |
| LATEST COMPANY NEWS. |
|
|
Feb 2, 2022 |
14373 |
| ImmunityBio Touts Promising Clinical Study Results for 'Kick and Kill' HIV Cure Strategy to Reduce HIV Viral Load with Anktiva (N-803) Therapy. |
|
Clinical report |
Feb 1, 2022 |
648 |
| Immunotherapy shows promise for children, young adults with recurrent AML. |
|
|
Feb 1, 2022 |
363 |
| Get up and running for Health Month.. |
|
|
Jan 31, 2022 |
251 |
| Immunotherapeutic PolyTope from ImmunoPrecise Potently Neutralizes the SARS-CoV-2 Omicron Variant Moves Towards FDA/IND-Submission. |
|
|
Jan 31, 2022 |
731 |
| Gonzales bares plans in first 100 days if elected president. |
|
|
Jan 31, 2022 |
563 |
| The wonders of the woodland. |
|
|
Jan 29, 2022 |
1215 |
